Found: 16
Select item for more details and to access through your institution.
High expression of HNRNPR in ESCA combined with <sup>18</sup>F-FDG PET/CT metabolic parameters are novel biomarkers for preoperative diagnosis of ESCA.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comprehensive Analysis of GLUT1 Immune Infiltrates and ceRNA Network in Human Esophageal Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.665388
- By:
- Publication type:
- Article
Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.606735
- By:
- Publication type:
- Article
DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04454-3
- By:
- Publication type:
- Article
DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04454-3
- By:
- Publication type:
- Article
FASTKD1 as a diagnostic and prognostic biomarker for STAD: Insights into m6A modification and immune infiltration.
- Published in:
- Experimental & Therapeutic Medicine, 2024, v. 28, n. 2, p. N.PAG, doi. 10.3892/etm.2024.12594
- By:
- Publication type:
- Article
Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.724741
- By:
- Publication type:
- Article
METTL3 as a novel diagnosis and treatment biomarker and its association with glycolysis, cuproptosis and ceRNA in oesophageal carcinoma.
- Published in:
- Journal of Cellular & Molecular Medicine, 2024, v. 28, n. 6, p. 1, doi. 10.1111/jcmm.18195
- By:
- Publication type:
- Article
Comprehensive Analysis of YTHDF1 Immune Infiltrates and ceRNA in Human Esophageal Carcinoma.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.835265
- By:
- Publication type:
- Article
Right ventricle performances with echocardiography and <sup>99m</sup>Tc myocardial perfusion imaging in pulmonary arterial hypertension patients.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 9, p. 754, doi. 10.1177/1535370218775321
- By:
- Publication type:
- Article
Nucleophosmin 1 overexpression correlates with 18F-FDG PET/CT metabolic parameters and improves diagnostic accuracy in patients with lung adenocarcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 3, p. 904, doi. 10.1007/s00259-020-05005-4
- By:
- Publication type:
- Article
Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-60581-x
- By:
- Publication type:
- Article
TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-54670-0
- By:
- Publication type:
- Article
TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-54670-0
- By:
- Publication type:
- Article
Uterine Burkitt Lymphoma with Rare Extranodal Deposits in the Bone, Breast, and Sacral Canal: A Case Report.
- Published in:
- OncoTargets & Therapy, 2024, v. 17, p. 41, doi. 10.2147/OTT.S440228
- By:
- Publication type:
- Article